Amydis Receives $3 Million NIH Commercialization Readiness Pilot Grant Award for Novel Amyloid Beta Retinal Tracer in Cerebral Amyloid Angiopathy
28 juin 2021 07h00 HE
|
Amydis, Inc.
SAN DIEGO, June 28, 2021 (GLOBE NEWSWIRE) -- Amydis Inc., a leading ocular tracer pharmaceutical company with a broad portfolio of diagnostic drug candidates targeting CNS biomarkers in the eye,...
Avricore Health Corporate Update Summer 2021
09 juin 2021 08h00 HE
|
Avricore Health Inc.
VANCOUVER, British Columbia, June 09, 2021 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is pleased to provide this corporate update on the Company’s successes in...
Avricore Health Signs Master Agreement to Pilot HealthTab™ Platform for Diabetes Management in Select Shoppers Drug Mart® Pharmacies
03 juin 2021 09h30 HE
|
Avricore Health Inc.
VANCOUVER, British Columbia, June 03, 2021 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce patients will soon have...
Avricore Health’s HealthTab™ Signs Distribution Agreement to Expand Pharmacy Network and Test Offering
31 mai 2021 08h00 HE
|
Avricore Health Inc.
VANCOUVER, British Columbia, May 31, 2021 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce the signing of a supplier...
Burning Rock Announces the Launch of China’s First Prospective Pan-Cancer Multi-omics Early Detection Study
19 mai 2021 05h06 HE
|
Burning Rock Biotech Limited
BEIJING, May 19, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced the launch of the PRESCIENT (Pan-canceR Early-Stage deteCtion by...
Amydis Announces Successful Completion of Pre-IND Meeting with the FDA for the Development of a First-in-Class Retinal Tracer for the Diagnosis of Alpha-synucleinopathies
26 avr. 2021 07h00 HE
|
Amydis, Inc.
SAN DIEGO, April 26, 2021 (GLOBE NEWSWIRE) -- Amydis Inc., a leading ocular tracer biotechnology company with a broad portfolio of diagnostic candidates for detection of neurodegenerative diseases...
Burning Rock’s Liquid Biopsy Assay Achieved Strong Performance in the FDA-led SEQC2 Study, with Results Published on Nature Biotechnology
13 avr. 2021 03h39 HE
|
Burning Rock Biotech Limited
GUANGZHOU, China, April 13, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that its liquid biopsy assay has achieved strong...
Avricore Health Announces Return of HealthTab™ Founder to Communications and Marketing Role
26 mars 2021 08h00 HE
|
Avricore Health Inc.
VANCOUVER, British Columbia, March 26, 2021 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR, OTC: AVCRF) (the "Company" or “AVCR”) is pleased to announce the return of HealthTab Co-Founder,...
Avricore Health Finalizes Agreement With Avrok Laboratories to Offer Real-Time Covid-19 Screening
18 mars 2021 08h30 HE
|
Avricore Health Inc.
The companies agree to offer HealthTab™ and COVID-19 rapid-antigen tests at resort locations, delivering fast and accurate results for travellers returning to the US. VANCOUVER, British Columbia,...
Avricore Health Partners With Avrok Laboratories to Offer Real-Time COVID-19 Screening for Travellers
16 févr. 2021 08h00 HE
|
Avricore Health Inc.
VANCOUVER, British Columbia, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce it has signed a Letter of...